HEATHER BURNSIDE: Open Payments
NPI 1942677307 · NORTH MUSKEGON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$600 in 30 payments from 14 companies in 2025. Trend: 2023 $871 · 2024 $1,172 · 2025 $600
Food & beverage: $600
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $136 |
| Astellas Pharma US Inc | 3 | $88 |
| AstraZeneca Pharmaceuticals LP | 5 | $79 |
| ABBVIE INC. | 2 | $57 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| Lilly USA, LLC | 2 | $40 |
| Amgen Inc. | 2 | $28 |
| Axsome Therapeutics, Inc. | 1 | $27 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
Products named: Veozah, Ozempic, Saxenda, REXULTI, MOUNJARO, FARXIGA, QULIPTA, BREZTRI.
Industry payments across MI — which companies pay providers there.
